Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

"Conformational and Immunogenicity Studies of the Shigella flexneri Serogroup 6 O-Antigen ... McKay, Bárbara Ibarzo Yus, Yoann Aldon, and Robin Shattock. "Inside out: optimization of lipid ...

While your body needs cholesterol, too much cholesterol—particularly low-density lipoprotein (LDL), often referred to as "bad" cholesterol—can raise the risk of heart disease. Lifestyle factors, such ...

Melanoma, known for its aggressive metastatic potential, poses significant treatment challenges. Despite the potent antiproliferative effects of anticancer drugs, systemic toxicity and low water ...

In a recent paper by Nikanjam and colleagues, synthetic low-density lipoprotein-like nanoparticles were prepared from commercial lipids and a bifunctional synthetic peptide containing the low ...

In the documentary, Hofmeister addressed her experience with low libido and other perimenopausal symptoms. For Hofmeister, her dwindling interest in sex seemed to be tied to an increase in midlife ...

Putting “fun” back into low- and middle-income Americans’ budgets could be years away with most of their income barely covering the surge in costs for bare necessities, economists said.

A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune response. It can help scientists and engineers expand the use of RNA ...

Before we discuss the exciting new discovery of cholesterol-based drugs, have you ever considered why your brain is white? It is because the brain synthesizes its own cholesterol through a process ...